BioRestorative Therapies BRTX Q1 2025 earnings
Reported May 14, 2025 · After market close
Revenue$25.0KMiss by $355.0K
EPS-$0.56Miss by $0.24
Revenue estimate$380.0K
EPS estimate-$0.32
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$600.0K
EPS estimate-$0.15
Versus estimates
Revenue
Diluted EPS
Ask the moment BioRestorative Therapies reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did BioRestorative Therapies report Q1 2025 earnings?
- BioRestorative Therapies (BRTX) reported Q1 2025 earnings on May 14, 2025 after market close.
- What were BioRestorative Therapies's Q1 2025 revenue and EPS?
- BioRestorative Therapies reported revenue of $25.0K and eps of $-0.56 for Q1 2025.
- Did BioRestorative Therapies beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $380.0K by $355.0K. EPS missed the consensus estimate of $-0.32 by $0.24.
- How did BioRestorative Therapies's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 28.6% from $35.0K a year earlier and eps declined 5.7% from $-0.53.
- Where can I find BioRestorative Therapies's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001641172-25-010299) directly on SEC EDGAR. The filing index links above go to sec.gov.